Uncover key drivers, emerging technologies, and competitive movements shaping the genetic mutation analysis market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Genetic Mutation Analysis Market size between 2026 and 2035?

The genetic mutation analysis market size has seen substantial growth in recent years. This market is set to expand from $6.65 billion in 2025 to $7.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The market’s expansion in the past can be attributed to several factors including limited availability of advanced sequencing technologies, increasing public awareness of genetic disorders, a rise in research activities focused on oncology and inherited diseases, the integration of PCR and microarray technologies, and the early introduction of bioinformatics tools.

The genetic mutation analysis market is projected to experience swift expansion in the coming years. This market is forecast to reach a size of $11.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.5%. Factors contributing to this growth during the projection period include progress in CRISPR and NGS platforms, the broadening of pharmacogenomics research, increased capital expenditure in genetic testing infrastructure, the incorporation of AI-powered data analysis tools, and a surge in partnerships between academic institutions and biotechnology firms. Key trends anticipated for the forecast timeframe encompass the growing utilization of next-generation sequencing and CRISPR technologies, a heightened need for personalized medicine and specific treatments, the broadening of genetic testing offerings in clinical diagnostics, the incorporation of bioinformatics and data analytics systems, and an uptick in studies focused on rare genetic conditions and pharmacogenomics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27297&type=smp

Which Drivers Are Impacting Market Performance In The Genetic Mutation Analysis Market?

The increasing incidence of genetic conditions is anticipated to fuel the expansion of the genetic mutation analysis market in the future. These conditions are illnesses resulting from deviations or alterations in a person’s DNA, which can be passed down through generations or manifest without apparent cause. A contributing factor to the growing occurrence of genetic disorders is the older age of parents, which elevates the chances of genetic changes during conception, thereby increasing the probability of these conditions appearing in children. Analysis of genetic mutations identifies gene modifications that can cause or indicate the existence of genetic disorders, facilitating prompt diagnosis, precise therapies, and educated choices regarding reproduction or lifestyle. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, reported that 11,148 cystic fibrosis patients were recorded in 2022, and this figure rose to 11,318 in 2023, indicating a 1.5% rise in patient registrations annually. Consequently, the growing frequency of genetic conditions is stimulating the expansion of the genetic mutation analysis market.

What Segment Types Are Examined In The Genetic Mutation Analysis Market?

The genetic mutation analysis market covered in this report is segmented –

1) By Component: Hardware, Software, Services

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics

4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories

Subsegments:

1) By Hardware: Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems

2) By Software: Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools

3) By Services: Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services

Which Trends Are Shaping Activity Within The Genetic Mutation Analysis Market?

Leading firms in the genetic mutation analysis market are concentrating on creating novel solutions, including tissue-based next-generation sequencing (NGS) tests, to improve accuracy in detecting relevant genetic changes and inform tailored treatment plans. Tissue-based next-generation sequencing (NGS) tests represent sophisticated diagnostic instruments that examine DNA or RNA sourced from a tissue specimen to identify genetic mutations, alterations, or biomarkers linked to conditions like cancer. For example, in June 2024, Guardant Health Inc., an oncology firm based in the US, introduced the Guardant360 TissueNext test, which increases the count of genes it identifies within a tumor tissue sample to 498. These genes, also known as cancer biomarkers, empower oncologists to pinpoint the most efficacious targeted therapies or treatment approaches for individuals suffering from advanced cancer. Beyond expanding the panel, Guardant has refined the test’s operational process to achieve a quicker turnaround time. The newly introduced Guardant360 TissueNext test will be covered as an independent service for Medicare fee-for-service patients diagnosed with advanced solid tumor cancers, following the coverage communicated by Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), in accordance with the current local coverage determination.

Who Are The Top-Performing Companies In The Genetic Mutation Analysis Market In Recent Years?

Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, BGI Genomics Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genetic-mutation-analysis-global-market-report

Which Region Currently Holds The Largest Share Of The Genetic Mutation Analysis Market?

North America was the largest region in the genetic mutation analysis market in 2025. The regions covered in the genetic mutation analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genetic Mutation Analysis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27297&type=smp

Browse Through More Reports Similar to the Global Genetic Mutation Analysis Market 2026, By The Business Research Company

Mining Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/mining-equipment-global-market-report

Electric Mining Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/electric-mining-equipment-global-market-report

Autonomous Mining Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/autonomous-mining-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.